Skip to main content
OpenTrials
Completed

NCT Number: NCT02911259

Suction on Post-Operative Chest Tubes

The level of suction on post-operative chest tubes after video-assisted thoracoscopic surgery (VATS) lobectomy for lung cancer has previously shown to affect duration of drainage. These results, however, are based on traditional drainage systems with water seal and need to be confirmed using digital drainage systems.

Hypothesis: Suction of -2 cmH2O is equal to or superior compared with standard suction of -10 cmH2O when looking at chest tube duration and complications.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non-small Cell Lung Cancer Bronchial Neoplasms Carcinoma, Bronchogenic Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rigshospitalet

Copenhagen, 2100, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Speaks and understands Danish.
  • Referred for planned VATS lobectomy for confirmed or suspected primary lung cancer.

Exclusion criteria

  • Cannot cooperate or unable to give consent.
  • Chronic drain carrier.
  • Planned open procedure.
  • Planned resection of additional wedge, additional lobe or thoracic wall.

Treatment and study plan

Suction is set to -2 cmH2O

Device

Post-operative suction is set to -2 cmH2O (intervention).

Suction is set to -10 cmH2O

Device

Post-operative suction is set to -10 cmH2O (standard treatment).

Primary outcomes

  1. Chest tube duration through study completion, an average of 3 days.

    Time frame: Through study completion, an average of 3 days.

    Time from intraoperative chest tube placement to it's removal.

Secondary outcomes

  1. Time to removal criteria have been fulfilled up to 24 hours

    Time frame: Duration from the post-operative chest tube has been placed, until it's potential removal.

    Chest tubes can be removed when the patient has been mobilized and the air leakage has not superceeded 20 mL/min in 12 hours and fluid production has not superceded 500 mL in 24 hours.

  2. Number of participants with prolonged air leak

    Time frame: Through study completion, an average of 7 days

  3. Number of participants requiring treatment for prolonged air leak.

    Time frame: Through study completion, an average of 14 days

  4. Number of participants requiring treatment for subcutaneous emphysema.

    Time frame: Through study completion, an average of 14 days

  5. Number of participants with pneumonia or empyema.

    Time frame: Through study completion, an average of 21 days

  6. Length of stay.

    Time frame: Through study completion, an average of 3 days

  7. Number of participants with other respiratory problems.

    Time frame: Through study completion, an average of 30 days

  8. Number of participants requiring readmission for thoracic surgical complications.

    Time frame: Through study completion, an average of 30 days

Sponsors and collaborators

Lead sponsor

Rigshospitalet, Denmark

Other

Collaborators

  • Medela AG

Registry information

Official study title

Suction on Post-Operative Chest Tubes After Video-Assisted Thoracoscopic Surgery Lobectomy for Presumed or Confirmed Primary Lung Cancer - At Which Level?

Acronym: SPOCT

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Sep 22, 2016
Registry last updated
Jul 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.